Evidence map›Paper›PMID 23363497›Full record

ArticleThe New England journal of medicine2013

Long-term functional outcomes after treatment for localized prostate cancer.

Matthew J Resnick, Tatsuki Koyama, Kang-Hsien Fan, Peter C Albertsen, Michael Goodman, Ann S Hamilton, Richard M Hoffman, Arnold L Potosky, Janet L Stanford, Antoinette M Stroup and 2 more

3 registry-linked trialsOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in The New England journal of medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 423 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
423citing papers in PubMed, 7 pooled it
85.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03561220 naactive not recruitingnot on this mapstarted 2018, after this paper: background citation

A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer

TypeinterventionalSponsorUniversity of FloridaRan2018 to 2027Enrolled3,000ConditionsProstate CancerArmsStandard of Care IMRT (Photon), Standard of Care Proton Therapy, Proton Arm 1: Standard Proton Therapy, Proton Arm 2: Hypofractionated Proton Therapy
NCT06056791 phase1 / phase2completednot on this mapstarted 2023, after this paper: background citation

An Open-label, Phase I/IIa Dose Escalation and Expansion Study to Determine the Safety and Clinical Activity of an Immune Priming Cell Therapy (INKmune) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

TypeinterventionalSponsorInmune Bio, Inc.Ran2023 to 2025Enrolled12ConditionsCancer, Metastatic Castration-resistant Prostate Cancer, mCRPCArmsINKmune
NCT07348367 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.

TypeinterventionalSponsorHenry Ford Health SystemRan2026 to 2028Enrolled160ConditionsProstatectomyArmsRadical Prostatectomy, Precision Prostatectomy
3 · Its place in the literature

Who cites it

423 citing papers in PubMed, 7 syntheses or guidelines pooled it, 947 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. African-American survivors of prostate cancer: a meta-synthesis of qualitative studies.Journal of cancer survivorship : research and practice · 2021
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Determining Barriers to Dietary Change Among Medically Underserved Men With Prostate Cancer.Health education & behavior : the official publication of the Society for Public Health Education · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

363 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Matthew J ResnickDepartment of Urologic Surgery and the Center for Surgical Quality and Outcomes Research, Vanderbilt University, Nashville, TN 37203, USA.
Tatsuki Koyama
Kang-Hsien Fan
Peter C Albertsen
Michael Goodman
Ann S Hamilton
Richard M Hoffman
Arnold L Potosky
Janet L Stanford
Antoinette M Stroup
R Lawrence Van Horn
David F Penson
Geriatric Research Education and Clinical Center · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAEmory University · USGeorgetown University · USUniversity of Connecticut · USUniversity of New Mexico · USUniversity of Southern California · USUniversity of Utah · USVanderbilt University · US

Funding

SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067009 · PC · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1996 to 2000
$3.0M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067007 · PC · UNIVERSITY OF NEW MEXICO · PI KEY, CHARLES R · 1996 to 2000
$2.4M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067010 · PC · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROSS, RONALD K · 1996 to 2000
$2.4M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067005 · PC · CONNECTICUT STATE DEPT OF PUBLIC HEALTH · PI POLEDNAK, ANTHONY · 1996 to 2000
$1.9M
Outcomes of Prostate Cancer Androgen Deprivation TherapyR01CA142934 · NCI · GEORGETOWN UNIVERSITY · PI POTOSKY, ARNOLD L · 2010 to 2012
$1.8M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067006 · PC · EMORY UNIVERSITY · PI YOUNG, JOHN L · 1996 to 2000
$1.7M
Race, Comorbidity & Long Term Prostate Cancer OutcomesR01CA114524 · NCI · VANDERBILT UNIVERSITY · PI PENSON, DAVID F. · 2007 to 2009
$1.7M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067000 · PC · UNIVERSITY OF UTAH · PI WIGGINS, CHARLES L · 1996 to 2000
$1.3M
NCI NIH HHS N01 PC067006NCI NIH HHS N01 PC067009NCI NIH HHS N01 PC067010NCI NIH HHS N01-PC-67000NCI NIH HHS N01-PC-67005NCI NIH HHS N01-PC-67006NCI NIH HHS N01-PC-67007NCI NIH HHS N01-PC-67009NCI NIH HHS R01 CA114524NCI NIH HHS R01-CA114524NCI NIH HHS R01 CA142934
6 · The paper itself

Abstract

backgroundThe purpose of this analysis was to compare long-term urinary, bowel, and sexual function after radical prostatectomy or external-beam radiation therapy.

methodsThe Prostate Cancer Outcomes Study (PCOS) enrolled 3533 men in whom prostate cancer had been diagnosed in 1994 or 1995. The current cohort comprised 1655 men in whom localized prostate cancer had been diagnosed between the ages of 55 and 74 years and who had undergone either surgery (1164 men) or radiotherapy (491 men). Functional status was assessed at baseline and at 2, 5, and 15 years after diagnosis. We used multivariable propensity scoring to compare functional outcomes according to treatment.

resultsPatients undergoing prostatectomy were more likely to have urinary incontinence than were those undergoing radiotherapy at 2 years (odds ratio, 6.22; 95% confidence interval [CI], 1.92 to 20.29) and 5 years (odds ratio, 5.10; 95% CI, 2.29 to 11.36). However, no significant between-group difference in the odds of urinary incontinence was noted at 15 years. Similarly, although patients undergoing prostatectomy were more likely to have erectile dysfunction at 2 years (odds ratio, 3.46; 95% CI, 1.93 to 6.17) and 5 years (odds ratio, 1.96; 95% CI, 1.05 to 3.63), no significant between-group difference was noted at 15 years. Patients undergoing prostatectomy were less likely to have bowel urgency at 2 years (odds ratio, 0.39; 95% CI, 0.22 to 0.68) and 5 years (odds ratio, 0.47; 95% CI, 0.26 to 0.84), again with no significant between-group difference in the odds of bowel urgency at 15 years.

conclusionsAt 15 years, no significant relative differences in disease-specific functional outcomes were observed among men undergoing prostatectomy or radiotherapy. Nonetheless, men treated for localized prostate cancer commonly had declines in all functional domains during 15 years of follow-up. (Funded by the National Cancer Institute.).

Indexed as

ProstatectomyAgedErectile DysfunctionFollow-Up StudiesHumansIntestinal DiseasesMaleMiddle AgedOutcome Assessment, Health CarePostoperative ComplicationsPrevalenceProstatic NeoplasmsRadiotherapyUrinary Incontinence

Identifiers

PMID23363497
PMCPMC3742365
OpenAlexW1968400906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.